$0.00
(0.00%
) Quote details
USD
$0.00
(0.00%
)At Close (As of Dec 5, 2025)
$1.39B
Market Cap
-
P/E Ratio
-0.33
EPS
$5.51
52 Week High
$1.05
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Taysha Gene Therapies, Inc. is a pioneering gene therapy company located in Dallas, Texas, focused on the development and commercialization of adeno-associated virus-based therapeutics for monogenic diseases impacting the central nervous system. The company boasts a strong pipeline of innovative treatments and utilizes a proprietary gene delivery platform to target significant unmet medical needs in neurology. As Taysha progresses through key clinical development milestones and forges strategic collaborations within the biopharmaceutical sector, it is well-positioned to make a transformative impact in the treatment landscape.
LPTX
WBD
IRBT
NVDA
SOFI
NFLX
ASST
BYND
INTC
PLUG
IPG
VALE
VHAI
ITUB
AAL
TSLA
DBRG
F
RGTI
ADAP
DNN
BITF
HPE
RR
PFE
GRAB
PBR
NFE
KEY
QBTS
MARA
NIO
BAC
SNAP
AMD
CLSK
DVLT
PLTR
TNFA
MTSR
T
GOOGL
IREN
APLD
PLTD
SMR
VZ
HBAN
CIFR
AVGO
CGC
BTBT
WMT
ORCL
AGNC
HOOD
MSFT
HIMS
PMCB
TWNP
MRVL
LPTX
WBD
IRBT
NVDA
SOFI
NFLX
ASST
BYND
INTC
PLUG
IPG
VALE
VHAI
ITUB
AAL
TSLA
DBRG
F
RGTI
ADAP
DNN
BITF
HPE
RR
PFE
GRAB
PBR
NFE
KEY
QBTS
MARA
NIO
BAC
SNAP
AMD
CLSK
DVLT
PLTR
TNFA
MTSR
T
GOOGL
IREN
APLD
PLTD
SMR
VZ
HBAN
CIFR
AVGO
CGC
BTBT
WMT
ORCL
AGNC
HOOD
MSFT
HIMS
PMCB
TWNP
MRVL